“Uncovering the Truth: Did Neumora Therapeutics Inc. Mislead Investors and Violate Shareholder Rights?”
Levi & Korsinsky Investigates Neumora Therapeutics, Inc. for Possible Securities Violations New York, NY / ACCESS Newswire / February 6, 2025 Investigation Commenced Into Neumora Therapeutics, Inc. (NASDAQ: NMRA) Levi & Korsinsky, a leading securities litigation firm, has announced that it has begun an investigation into Neumora Therapeutics, Inc. (NASDAQ: NMRA) for potential violations of…